Organization

U-CAN's highest level of management is the Program Council which consists of representatives from the four participating universities. The role of the Program Council is to oversee and follow up on the project with regard to the sample collection, the economy, the reseach activities and to make strategic decisions.

The Program Council consists of five members: two from Uppsala University, and one member each from Umeå University, Stockholm University and KTH Royal Institute of Technology. The Program Council is organizationally attached to the Disciplinary Domain of Medicine and Pharmacy at Uppsala University which provide intructions and guidelines to the Program Council.

Members of the Program Council

• Karin Forsberg-Nilsson, Professor, Professor, Dean, Uppsala University (chairman)
• Katrine Riklund, Professor, Deputy Vice-Chancellor, Umeå University
• Cecilia Williams, Professor, KTH Royal Institute of Technology
• Lena Mäler, Professor, Stockholm University
• Sören Lehmann, Professor, Uppsala University

Adjunct members of the Program Council

• Tobias Sjöblom, Professor, U-CAN Program Director, Uppsala universitet
• Cecilia Lindskog, PhD, U-CAN Administrative Director, Uppsala University
• Maréne Landström, Professor, Head of U-CAN at Umeå University

The Program Board leads the practical aspects of U-CANs operations and overall development. The Program Board is also responsible for making the final decision concering applications for using U-CAN material for research.

The chairman of the Program Board is the U-CAN Program Director. The Program Board furthermore consists of two members from Uppsala University, two members from Umeå University and (alternating) one member from either Stockholm University or KTH Royal Institute of Technology.

Chairman

• Tobias Sjöblom, Program Director for U-CAN, Uppsala

Members

• Maréne Landström, Umeå
• Ingrid Ljuslinder and Camilla Thellenberg Karlsson (shared position), Umeå
• Mats Hellström, Uppsala
• Patrick Micke, Uppsala
• Jochen Schwenk, KTH

Adjunct member

• Cecilia Lindskog, Administrative Director for U-CAN, Uppsala

The Executive Committees in Uppsala och Umeå are responsible for coordinating the practical aspects of U-CANs project plan concerning the collection of samples and data at the respective sites. The Executive Committees consists of representatives from all active diagnsis groups along with representatives from the biobank and pathology department.

Uppsala

Chairman

• Tobias Sjöblom, Program Director for U-CAN, or
• Cecilia Lindskog, Administrative Director for U-CAN (stand in for the Program Director)

Members

• Mats Ahlberg, kidney cancer
• Håkan Ahlström, radiology
• Anna Beskow, biobank
• Gunilla Enblad, lymphoma
• Malin Enblad, colorectal cancer
• Petter Früling, liver metastases
• Ingrid Glimelius, lymphoma and testicular cancer
• Mohammad Haghsheno, testicular cancer
• Anna-Karin Haylock, head-/neck cancer
• Jakob Hedberg, gastric- and esophageal cancer
• Vivan Hellström, cancer in organ transplanted
• Göran Hesselager, brain tumors
• Michael Häggman, prostate cancer
• Martin Höglund, haematological malignancies
• Bengt Isaksson, liver-, bile duct and pancreatic cancer
• Henrik Lindman, breast cancer
• Irina Alafuzoff, pathology
• Oscar Simonson, lung cancer
• Karin Stålberg, gynecologic cancer
• Peter Stålberg, neuroendokrine tumors

Umeå

Chairman

• Maréne Landström, Head of U-CAN at Umeå University

Members

• Magnus Hultdin, haematology, vice chairman
• Mikael Johansson, lung cancer
• Beatrice Melin, brain tumors
• Camilla Thellenberg-Karlsson, prostate cancer
• Ingrid Ljuslinder, colorectal cancer
• Martin Rutegård, colorectal cancer
• Ove Björ, statistician
• Ulrika Andersson, project coordinator U-CAN Umeå

The diagnosis groups are locally organized in both Uppsala and Umeå and their main task is to develop and maintain U-CANs routines for the collection of samples and data. The diagnosis groups also review research applications within their respective areas and are tasked with leaving a decision recommendation to the Program Board. If a diagnosis area has diagnosis groups at both the Uppsala and Umeå sites, the two groups work in close collaboration.

A diagnosis group must consist of at least five members that all share an interest in running and mainitaining the collection of samples and data according to the U-CAN model:

• One surgeon or equivalent
• One oncologist
• One pathologist
• One translational cancer researcher
• One reseasch nurse

Apart from these set roles and members, the diagnosis group may freely include other clinicians and/or researchers in order to gain special competences and/or increase the interest in maintaining the work and driving the research forward.

Lead the work in the diagnosis groups at the different hospitals.

Colorectal cancer

• Uppsala: Malin Enblad
• Umeå: Ingrid Ljuslinder
• Nodansvarig Gävle: Sepher Doroudian

Haematologcal malignancies and lymphoma

• Uppsala haematologi: Martin Höglund
• Uppsala lymphoma: Gunilla Enblad
• Umeå: Magnus Hultdin
• Node responsible Västerås: Josefin Hidman
• Node responsible Gävle: Helena Gustafsson
• Node responsible for lymphoma Falun/Karlstad/Gävle: Gunilla Enblad

Prostate cancer

• Uppsala: Michael Häggman
• Umeå: Camilla Thellenberg Karlsson

Brain tumors

• Uppsala: Göran Hesselager
• Umeå: Beatrice Melin

Neuroendokrine tumors

• Uppsala: Peter Stålberg

Gynecologic cancer

• Uppsala: Karin Stålberg
• Node responsible Gävle: Hanna Rapp

Breast cancer

• Uppsala: Henrik Lindman

Lung cancer

• Uppsala: Oscar Simonson
• Umeå: Mikael Johansson
• Node responsible Gävle/Falun: Johan Isaksson

Gastric and esophageal cancer

• Uppsala: Jakob Hedberg

Head and neck cancer

• Uppsala: Anna-Karin Haylock

Cancer in organ transplanted patients

• Uppsala: Vivan Hellström

Kidney cancer

• Uppsala: Mats Steinholtz Ahlberg

Testicular cancer

• Uppsala: Mohammad Haghsheno

Cancer-Covid

• Uppsala: Gunilla Enblad